Day: September 17, 2025

Peer-reviewed publication highlights potential breakthrough anti-fibrotic properties of LTI-03 in lung tissue from IPF patients AUSTIN, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) — Rein Therapeutics (“Rein”) (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced the publication of novel data on its lead drug candidate, LTI-03, in iScience, a peer-reviewed, open-access journal published by Cell Press. The paper, titled “LTI-03 peptide demonstrates anti-fibrotic activity in ex vivo lung slices from IPF patients,” reports how LTI-03 was tested directly on lung tissue donated by patients with idiopathic pulmonary fibrosis (IPF) who underwent lung transplant. In this model, LTI-03...

HAUPPAUGE, N.Y., Sept. 17, 2025 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced the expansion of its commercial lending platform with the addition of several seasoned banking professionals. The following individuals have joined Dime:Ryan Kent has joined as Director of Commercial Strategic Initiatives. He was previously a Senior Manager at Deloitte and prior to that a Senior Managing Director at Webster Bank Elvis Grgurovic has joined as Co-Head of the Mid Corporate vertical. He was previously a Managing Director at Webster Bank Eric Pelletier has joined as Head of Syndications. He was previously a Managing Director at Webster Bank Matt Greene has joined as a Senior Vice President in the Mid-Corporate and Specialty Finance...

BOSTON, Sept. 17, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that the promising development program and potential benefits of neflamapimod for the treatment of Dementia with Lewy Bodies (DLB) were highlighted in a presentation on advances in DLB drug development by Dr. James Galvin at the 150th Annual American Neurological Association (ANA) conference held September 13-16, 2025 in Baltimore, Maryland. “We are excited to continue showcasing neflamapimod’s promising disease-modifying benefit at ANA. Following the positive data showing neflamapimod reduced the risk of clinically significant worsening on the Clinical Dementia Rating Sum of Boxes (CDR-SB) in our Phase 2b trial, including...

Access to additional capital further strengthens Digital Asset Treasury execution strategy Preferred converts to common stock at $250 per Caliber share SCOTTSDALE, Ariz., Sept. 17, 2025 (GLOBE NEWSWIRE) — Caliber (NASDAQ: CWD), a diversified real estate and digital asset management platform, today announced that it has closed a securities purchase agreement with an institutional investor for the sale of $15.9 million of perpetual convertible preferred equity and, separately, has established and activated an At-The-Market (ATM) equity program. Under the preferred investment, Caliber issued 15,868 shares of Series B Preferred Stock at a purchase price of $1,000 per share, resulting in gross proceeds of $15,868,000. The Series B Preferred Stock is convertible, at the holder’s option, into Caliber common shares at $250 per share....

Arch acquires a new CKD platform that has the potential to produce next-generation CKD drugs for the pharmaceutical industryBased on a novel mechanism of action involving IL-32 and directly implicated in CKD, discovered in pre-clinical studies led by Dr. Justin ChunThe Company has filed both composition and method of use patents relating to the CKD platform.The Arch CKD program will be led by Dr. Justin Chun, who joins the Company as a Principal ScientistCKD is largely an unmet medical need, currently affecting more than 800 million people worldwide and approximately 35 to 38 million in the U.S.TORONTO, Sept. 17, 2025 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), today announced it has acquired a pre-clinical platform developing new drugs to treat chronic...

HOUSTON, Sept. 17, 2025 (GLOBE NEWSWIRE) — KBR (NYSE: KBR) announced today it has been awarded three cost-plus-fixed-fee task order contracts by the Air Force Research Laboratory (AFRL) under the Innovative Cyber/Infrastructure Threat Assessment Environment (INCITE) Common Operating Picture for Event Response Situation Awareness (COPERS) contract. The Multi-Domain Situational Awareness task order, Trusted Microelectronics, Mission Resilience and Assessment Environments task order and the Space Situational Awareness and the Mission Assurance in Space Operations task order collectively total $175 million. The contracts focus on the continued development and implementation of advanced situational awareness technologies across multiple domains. They also enhance mission assurance and Command, Control, Communications, Computers, Intelligence,...

Highlights:RecycLiCo to test the amenability of its hydrometallurgical processes to create refined metal products from Alaska Energy Metal’s Nikolai deposit, Alaska. Successful application of hydrometallurgical refining of metal concentrates on site at the Nikolai deposit in Alaska would create a wholly American, secure supply chain for nickel, cobalt and a variety of other critical and strategic metals.DELTA, British Columbia, Sept. 17, 2025 (GLOBE NEWSWIRE) — RecycLiCo Battery Materials Inc. (“RecycLiCo”) (TSX.V: AMY | OTCQB: AMYZF | FSE: ID4), a critical mineral refining and lithium-ion battery upcycling company, and Alaska Energy Metals Corp. (“AEMC”) (TSX.V: AEMC | OTCQB: AKEMF | FRA: V7F) are pleased to announce that RecycLiCo’s new wholly owned U.S. subsidiary, RecycLiCo US Mineral Recovery, Inc. (“RUMR”) and AEMC have...

Nokia CorporationStock Exchange Release17 September 2025 at 13:00 EEST Nokia announces changes to its leadership team and the creation of Technology and AI and Corporate Development Organizations   Nokia announces the creation of two new teams, a Technology and AI Organization (TAO) and a Corporate Development Organization (CDO) to strengthen the company’s capabilities in technology innovation, bring better support to business development and create more focused organizations.   Pallavi Mahajan to join Nokia as Chief Technology and AI Officer and Konstanty Owczarek to join Nokia as Chief Corporate Development Officer. Both Mahajan and Owczarek will join Nokia’s Group Leadership Team on 1 October 2025.   Nishant Batra has decided to step down as Chief Strategy and Technology Officer and from the Group Leadership Team effective 30 September...

GUANGZHOU, China, Sept. 17, 2025 (GLOBE NEWSWIRE) — French Ambassador to China, Mr. Bertrand Lortholary, led a delegation to visit WeRide (Nasdaq: WRD), a global leader in autonomous driving technology, earlier this week, to learn more about the company’s operations and future plans in France.The delegation included Mr. Christian Gianella, Minister Counsellor for Economic Affairs at the French Embassy, and Mr. Laurent Legodec, Consul General of France in Guangzhou. They were welcomed by WeRide’s Founder and CEO Dr. Tony Han and other company representatives. During the visit, the delegation experienced WeRide’s autonomous Robotaxi and Robobus, observing their smooth performance and safety despite rainy conditions. A roundtable discussion followed, where WeRide presented its company journey, flagship products,...